1. Home
  2. LEA vs RGEN Comparison

LEA vs RGEN Comparison

Compare LEA & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lear Corporation

LEA

Lear Corporation

HOLD

Current Price

$131.32

Market Cap

6.3B

ML Signal

HOLD

Logo Repligen Corporation

RGEN

Repligen Corporation

HOLD

Current Price

$138.13

Market Cap

6.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LEA
RGEN
Founded
1917
1981
Country
United States
United States
Employees
N/A
N/A
Industry
Auto Parts:O.E.M.
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.3B
6.6B
IPO Year
1994
1995

Fundamental Metrics

Financial Performance
Metric
LEA
RGEN
Price
$131.32
$138.13
Analyst Decision
Buy
Buy
Analyst Count
14
12
Target Price
$132.21
$167.67
AVG Volume (30 Days)
488.4K
749.1K
Earning Date
05-01-2026
04-30-2026
Dividend Yield
2.39%
N/A
EPS Growth
N/A
286.96
EPS
8.15
0.86
Revenue
$23,259,100,000.00
$141,236,000.00
Revenue This Year
$2.50
$14.30
Revenue Next Year
$3.12
$14.52
P/E Ratio
$15.83
$153.93
Revenue Growth
N/A
35.10
52 Week Low
$81.62
$109.66
52 Week High
$142.84
$175.77

Technical Indicators

Market Signals
Indicator
LEA
RGEN
Relative Strength Index (RSI) 64.22 68.57
Support Level $115.26 $111.29
Resistance Level $142.84 $172.45
Average True Range (ATR) 3.05 4.89
MACD 1.17 2.60
Stochastic Oscillator 96.92 89.82

Price Performance

Historical Comparison
LEA
RGEN

About LEA Lear Corporation

Lear Corp designs, develops, and manufactures automotive seating and electrical systems and components. The company has two reporting segments Seating and E-Systems. Seating components include frames and mechanisms, covers (leather and woven fabric), seat heating and cooling, foam, and headrests. Automotive electrical distribution and connection systems and electronic systems include wiring harnesses, terminals and connectors, on-board battery chargers, high-voltage battery management systems. The company earns majority of its revenue from the seating segment.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category (about 55% of total revenue), while chromatography, proteins, and process analytics are 21%, 11%, and 13%, respectively. Customers in North America, Europe, and Asia Pacific contribute about 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: